Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502125 · ClinicalTrials.gov registry record
In Vivo Confocal Imaging of Oral Mucosa
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 12
- Enrollment target
NCT00502125: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00502125 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00502125 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the feasibility of using reflectance confocal imaging to noninvasively detect and diagnose oral dysplasia and early carcinoma.
Interventions
- PROCEDURE Reflectance Confocal Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2003-01 |
| Est. Completion | 2009-09 |
What the finished NCT00502125 record still lists
NCT00502125 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Reflectance Confocal Imaging is the first listed.
NCT00502125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00502125 about?
NCT00502125 is a clinical study titled "In Vivo Confocal Imaging of Oral Mucosa". The objective of this study is to evaluate the feasibility of using reflectance confocal imaging to noninvasively detect and diagnose oral dysplasia and early carcinoma.
What is the current status of trial NCT00502125?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2003-01. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00502125?
The interventions under investigation include: Reflectance Confocal Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00502125?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia